ICD-10 codes used to identify adverse drug events in administrative data: a systematic review
- PMID: 24222671
- PMCID: PMC3994866
- DOI: 10.1136/amiajnl-2013-002116
ICD-10 codes used to identify adverse drug events in administrative data: a systematic review
Erratum in
- J Am Med Inform Assoc. 2014 Jul-Aug;21(4):757. Doyle-Waters, Mimi [added]
Abstract
Background: Adverse drug events, the unintended and harmful effects of medications, are important outcome measures in health services research. Yet no universally accepted set of International Classification of Diseases (ICD) revision 10 codes or coding algorithms exists to ensure their consistent identification in administrative data. Our objective was to synthesize a comprehensive set of ICD-10 codes used to identify adverse drug events.
Methods: We developed a systematic search strategy and applied it to five electronic reference databases. We searched relevant medical journals, conference proceedings, electronic grey literature and bibliographies of relevant studies, and contacted content experts for unpublished studies. One author reviewed the titles and abstracts for inclusion and exclusion criteria. Two authors reviewed eligible full-text articles and abstracted data in duplicate. Data were synthesized in a qualitative manner.
Results: Of 4241 titles identified, 41 were included. We found a total of 827 ICD-10 codes that have been used in the medical literature to identify adverse drug events. The median number of codes used to search for adverse drug events was 190 (IQR 156-289) with a large degree of variability between studies in the numbers and types of codes used. Authors commonly used external injury (Y40.0-59.9) and disease manifestation codes. Only two papers reported on the sensitivity of their code set.
Conclusions: Substantial variability exists in the methods used to identify adverse drug events in administrative data. Our work may serve as a point of reference for future research and consensus building in this area.
Keywords: Administrative Data; Comparative Effectiveness and Safety Research; Drug Safety; International Classification of Diseases; Patient Safety.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Defining pediatric traumatic brain injury using International Classification of Diseases Version 10 Codes: a systematic review.BMC Neurol. 2015 Feb 4;15:7. doi: 10.1186/s12883-015-0259-7. BMC Neurol. 2015. PMID: 25648197 Free PMC article. Review.
-
A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data.Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:148-53. doi: 10.1002/pds.2340. Pharmacoepidemiol Drug Saf. 2012. PMID: 22262601 Review.
-
Use of ICD-10-CM T codes in hospital claims data to identify adverse drug events in Taiwan.J Clin Pharm Ther. 2021 Apr;46(2):476-483. doi: 10.1111/jcpt.13308. Epub 2020 Nov 18. J Clin Pharm Ther. 2021. PMID: 33210301
-
Comprehensive review of ICD-9 code accuracies to measure multimorbidity in administrative data.BMC Health Serv Res. 2020 Jun 1;20(1):489. doi: 10.1186/s12913-020-05207-4. BMC Health Serv Res. 2020. PMID: 32487087 Free PMC article. Review.
Cited by
-
Risk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection: impact of COVID-19 and derivation and validation of risk prediction models.BMC Med. 2024 Jul 2;22(1):277. doi: 10.1186/s12916-024-03480-2. BMC Med. 2024. PMID: 38956603 Free PMC article.
-
Accuracy assessment of patient safety incident (PSI) codes and present-on-admission (POA) indicators: a cross-sectional analysis using the Patient Safety Incidents Inquiry (PSII) in Korea.BMC Health Serv Res. 2024 Jun 21;24(1):755. doi: 10.1186/s12913-024-11210-w. BMC Health Serv Res. 2024. PMID: 38907291 Free PMC article.
-
A Genetic Analysis of Current Medication Use in the UK Biobank.J Pers Med. 2024 Mar 20;14(3):319. doi: 10.3390/jpm14030319. J Pers Med. 2024. PMID: 38541061 Free PMC article.
-
Enhancing antidepressant safety surveillance: comparative analysis of adverse drug reaction signals in spontaneous reporting and healthcare claims databases.Front Pharmacol. 2024 Jan 8;14:1291934. doi: 10.3389/fphar.2023.1291934. eCollection 2023. Front Pharmacol. 2024. PMID: 38259269 Free PMC article.
-
Clarification of adverse drug reactions by a pharmacovigilance team results in increased antibiotic re-prescribing at a freestanding United States children's hospital.PLoS One. 2024 Jan 12;19(1):e0295410. doi: 10.1371/journal.pone.0295410. eCollection 2024. PLoS One. 2024. PMID: 38215178 Free PMC article.
References
-
- Gu Q, Dillon CF, Burt VL. Prescription drug use continues to increase: US prescription drug data for 2007–2008. NCHS Data Brief 2010. http://www.cdc.gov/nchs/data/databriefs/db42.pdf (accessed 9 Feb 2013).
-
- Nebeker J, Barach P, Samore M. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004;140:795–801 - PubMed
-
- Bates D. Drugs and adverse drug reactions. How worried should we be? JAMA 1998;279:1216–17 - PubMed
-
- Slone Epidemiology Center. Patterns of Medication Use in the United States 2004: a Report from the Slone Survey. 2004. http://www.bu.edu/slone/SloneSurvey/AnnualRpt/SloneSurveyWebReport2006.pdf (accessed April 2010).
-
- Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107–16 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
